Results 31 to 40 of about 23,130 (216)

Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: More Stone than Bone? [PDF]

, 2012
Introduction. Normocalcemic primary hyperparathyroidism (NPHPT) is considered a variant of the more frequent form of the disease characterized by normal serum calcium levels with high PTH.
Amaral, L. M., Bandeira, F., Marques, T. F., Mendes, M., Queiroz, D. C.   +4 more
core   +5 more sources

Approach to the Patient: Normocalcemic Primary Hyperparathyroidism

The Journal of Clinical Endocrinology & Metabolism
Abstract Normocalcemic primary hyperparathyroidism (NPHPT), a phenotype of primary hyperparathyroidism, is characterized by elevated parathyroid hormone levels in the setting of persistently normal serum calcium. Diagnosis of NPHPT can be challenging and requires that secondary causes of hyperparathyroidism be excluded.
Yi Liu, Naina Sinha Gregory, Panagiota Andreopoulou, Sangeeta Kashyap, Natalie Cusano   +4 more
openaire   +3 more sources

Nephrolithiasis in hypercalcemic and normocalcemic primary Hyperparathyroidism [PDF]

Archives of Renal Diseases and Management, 2017
Primary hyperparathyroidism (PHPT) is a common condition affecting up to 4 per 1000 of population, and the majority of cases are due to adenoma or hyperplasia of the gland [1].
VM dos Santos
openalex   +2 more sources

Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism. [PDF]

Vasc Health Risk Manag, 2017
Mesquita PN, Dornelas Leão Leite AP, Chagas Crisóstomo SD, Veras Filho E, da Cunha Xavier L, Bandeira F.   +5 more
europepmc   +3 more sources

High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism [PDF]

Kidney and Blood Pressure Research, 2019
<b><i>Introduction:</i></b> Normocalcemic primary hyperparathyroidism (NPHPT) is characterized by elevations in serum parathyroid hormone levels in the presence of normal serum calcium concentrations after exclusion of secondary hyperparathyroidism.
Alyne Layane Pereira Lemos, Sergio Ricardo de Lima Andrade, Lívia Laeny Henrique Pontes, Patricia Moura Cravo Teixeira, Elba Bandeira, Leonardo C. Bandeira, Francisco Bandeira   +6 more
openaire   +4 more sources

Normocalcemic primary hyperparathyroidism associated with fibrocalculous pancreatic disease & vitamin D deficiency: A case report

Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh
Normo-calcemic primary hyperparathyroidism (NHPT) is a disorder in which elevated parathyroid hormone (PTH) is the result of autonomic hypersecretion of parathyroid hormone from 1 or more parathyroid glands, and the serum calcium levels are consistently ...
Syeda Fahmida Afrin
openalex   +3 more sources

Normocalcemic Primary Hyperparathyroidism Presenting with Muscle Weakness and Body Pain. [PDF]

Intern Med, 2021
Mihashi I, Ishii K, Ogawa Y, Uchida A, Hara H, Tamaoka A.   +5 more
europepmc   +3 more sources

¹⁸F-Fluorocholine-Positron Emission Tomography/Computerised Tomography is Useful in Localising ^99mTc-Sesta-methoxyisobutylisonitrile-Negative Parathyroid Cyst Causing Normocalcemic Primary Hyperparathyroidism. [PDF]

Eur Endocrinol, 2018
Dutta D, Gupta PK, Sharma M, Damble NA, Madan R, Dogra S.   +5 more
europepmc   +3 more sources

Three Malagasy Cases of Severe Bone Complications Revealing Primary Hyperparathyroidism. [PDF]

Case Rep Endocrinol
Primary hyperparathyroidism (PHPT) is a metabolic disorder characterized by hypercalcemia with elevated or unsuppressed parathyroid hormone (PTH). It is rare in children but common in adults, particularly in women around the age of 50. In 85% of cases, PHPT is asymptomatic and is diagnosed following hypercalcemia and elevated PTH levels during routine ...
Andrianadison Z, Rakotonirina LN, Rakotonirainy OH, Andrianiaina MO, Rakotomahefa MNL, Rapelanoro Rabenja F.   +5 more
europepmc   +2 more sources

Paget's Disease of Bone and Normocalcemic Variant of Primary Hyperparathyroidism in an Osteoporotic Male: Exceptional Coexistence. [PDF]

Reports (MDPI)
Gheorghe AM, Ionescu OP, Costachescu M, Sima OC, Carsote M.   +4 more
europepmc   +3 more sources